Infectious Disease Control Section, Health and Safety Division, Bureau of Social Welfare and Public Health, Tokyo Metropolitan Government.
National Institute of Infectious Diseases.
Tohoku J Exp Med. 2020 May;251(1):39-46. doi: 10.1620/tjem.251.39.
In Japan, the reported cases of syphilis have been increasing since 2011 especially in large cities such as Tokyo. The objective of this study was to evaluate the risk of HIV infection for syphilis co-infection on the population of Tokyo, Japan. We analyzed data of syphilis cases obtained from additional surveillance by the Tokyo Metropolitan Government in 2018, including those with human immunodeficiency virus (HIV) infection as well as data of HIV/acquired immunodeficiency syndrome (AIDS) cases during 1985-2017. We calculated the incidence of symptomatic syphilis cases among HIV-infected or non-HIV-infected individuals. Similarly, we calculated the incidence of syphilis, including asymptomatic cases, among each population. The relative risk of HIV infection for syphilis, including or excluding asymptomatic syphilis cases, was estimated. The relative risk was calculated by dividing the incidence of syphilis in the HIV-infected population by that in the non-HIV-infected population. Of the 1,775 syphilis cases reported in 2018, 172 cases were infected with HIV, 575 cases were uninfected, and the remainder were either unknown or not reported. The cumulative number of HIV/AIDS cases during 1985-2017 in Tokyo was 9,629; among them, 172 were co-infected with syphilis. The relative risk of HIV infection for syphilis was estimated as 423.29 if asymptomatic syphilis cases were included, and 372.37 if they were excluded. These results showed an extremely high risk of HIV infection. Since many syphilis cases have unknown or unreported HIV infection status, reduction of these cases might contribute to more reliable estimation of HIV infection risk.
在日本,自 2011 年以来,梅毒报告病例一直在增加,尤其是在东京等大城市。本研究旨在评估日本东京人群梅毒合并感染 HIV 感染的风险。我们分析了 2018 年东京都政府额外监测获得的梅毒病例数据,包括感染人类免疫缺陷病毒(HIV)以及 1985-2017 年 HIV/获得性免疫缺陷综合征(AIDS)病例的数据。我们计算了 HIV 感染者和非 HIV 感染者中症状性梅毒病例的发病率。同样,我们计算了每个人群中包括无症状病例在内的梅毒发病率。估计了包括或不包括无症状梅毒病例的 HIV 感染与梅毒的相对风险。相对风险通过将 HIV 感染者的梅毒发病率除以非 HIV 感染者的梅毒发病率来计算。在 2018 年报告的 1775 例梅毒病例中,有 172 例感染了 HIV,575 例未感染,其余病例或未知或未报告。1985-2017 年期间,东京共报告了 9629 例 HIV/AIDS 病例,其中 172 例合并感染了梅毒。如果包括无症状梅毒病例,HIV 感染梅毒的相对风险估计为 423.29,如果不包括无症状梅毒病例,则为 372.37。这些结果表明 HIV 感染的风险极高。由于许多梅毒病例的 HIV 感染状况未知或未报告,减少这些病例可能有助于更可靠地估计 HIV 感染风险。